Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,743,000 | 6,979,000 | 5,901,000 | 2,760,988 | 74,537 |
| Marketable Securities | 11,000 | 500,000 | 2,075,000 | 1,824,617 | N/A |
| Receivables | 3,755,000 | 4,299,000 | 4,298,000 | 3,097,510 | 2,994,005 |
| Inventories | 1,085,000 | 1,037,000 | 1,091,000 | 958,878 | 862,775 |
| Income taxes - deferred | 1,442,000 | 1,397,000 | 669,000 | 2,288,746 | 2,061,643 |
| Other current assets | 0 | 0 | 0 | 1 | 0 |
| TOTAL | $15,662,000 | $14,923,000 | $15,354,000 | $10,930,740 | $5,992,960 |
| Non-Current Assets | |||||
| PPE Net | 2,213,000 | 2,200,000 | 2,247,000 | 2,138,898 | 2,092,021 |
| Investments And Advances | 121,000 | 118,000 | 119,000 | 202,619 | 237,003 |
| Intangibles | 8,221,000 | 8,213,000 | 8,453,000 | 8,523,259 | 8,513,855 |
| Other Non-Current Assets | 1,693,000 | 1,715,000 | 835,000 | 934,464 | 873,711 |
| TOTAL | $12,248,000 | $12,246,000 | $11,654,000 | $11,799,240 | $11,716,590 |
| Total Assets | $27,910,000 | $27,169,000 | $27,008,000 | $22,729,980 | $17,709,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 432,000 | 436,000 | 1,042,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,373,000 | 6,330,000 | 5,734,000 | 423,907 | 337,118 |
| Accrued Expenses | N/A | N/A | N/A | 1,697,849 | 1,495,066 |
| Other current liabilities | N/A | N/A | N/A | 520,460 | 438,367 |
| TOTAL | $6,805,000 | $6,766,000 | $6,776,000 | $5,367,892 | $4,839,721 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,326,000 | 14,601,000 | 14,630,000 | N/A | N/A |
| Other Non-Current Liabilities | 3,221,000 | 2,845,000 | 2,239,000 | 1,693,251 | 1,364,758 |
| TOTAL | $17,547,000 | $17,446,000 | $16,869,000 | $1,693,251 | $1,364,758 |
| Total Liabilities | $24,352,000 | $24,212,000 | $23,645,000 | $7,061,143 | $6,204,479 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,585,429 | 1,583,729 | 1,577,334 | N/A | N/A |
| Common Shares | 16,000 | 16,000 | N/A | N/A | N/A |
| Retained earnings | 758,000 | 330,000 | N/A | N/A | N/A |
| Other shareholders' equity | -1,169,000 | -1,237,000 | 3,363,000 | 15,668,840 | 11,505,080 |
| TOTAL | $3,558,000 | $2,957,000 | $3,363,000 | $15,668,840 | $11,505,080 |
| Total Liabilities And Equity | $27,910,000 | $27,169,000 | $27,008,000 | $22,729,983 | $17,709,559 |